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Abstract
In this manuscript we describe for the first time mirror image catalytic nucleic acids (Spiegelzymes), which hydrolyze
sequence specifically L-ribonucleic acid molecules. The mirror image nucleic acid ribozymes designed are based upon the
known hammerhead ribozyme and DNAzyme structures that contain L-ribose or L-deoxyribose instead of the naturally
occurring D-ribose or D-deoxyribose, respectively. Both Spiegelzymes show similar hydrolytic activities with the same L-RNA
target molecules and they also exhibit extra ordinary stabilities when tested with three different human sera. In this respect
they are very similar to Spiegelmers (mirror image aptamers), which we had previously developed and for which it has been
shown that they are non-toxic and non-immunogenic. Since we are also able to demonstrate that the hammerhead and
DNAzyme Spiegelzymes can also hydrolyze mirror image oligonucleotide sequences, like they occur in Spiegelmers, in vivo,
it seems reasonable to assume that Spiegelzymes may in principle be used as an antidote against Spiegelmers. Since the
Spiegelzymes contain the same building blocks as the Spiegelmers, it can be expected that they will have similar favorable
biological characteristics concerning toxicity and immunogenety. In trying to understand the mechanism of action of the
Spiegelzymes described in this study, we have initiated for the first time a model building system with L-nucleic acids. The
models for L-hammerhead ribozyme and L-DNAzyme interaction with the same L-RNA target will be presented.
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Introduction
Within the last 30 years it became apparent that natural nucleic
acids may possess, besides their traditionally known functions in
gene expression, an unforeseen structural and functional reper-
toire. This could range from enzymatic to high affinity binding
functions. In vitro selection techniques were developed to produce
high affinity nucleic acids, called aptamers, and also different types
of ribozymes and DNAzymes. Thus, it was established that RNA
and DNA molecules can be selected to carry out functions that
were previously solely attributed to proteins [1].
Nucleic acid aptamers are single stranded DNA or RNA
oligonucleotides, which are capable of adopting structures that
bind any target imaginable with very high specificities and
affinities. Thus, the binding properties of RNA and DNA
aptamers can make them to excellent alternatives to antibodies
[1,2]. However, the use of aptamers is severely limited by the
susceptibility of nucleic acids, and here especially of RNAs, to the
hydrolysis by ubiquitous nucleases [3,4]. The problem of the
instability of RNA molecules can partially be overcome by
chemical modifications [5,6]. Another very promising possibility of
obtaining very stable RNA aptamers has been previously been
demonstrated by us with the development of Spiegelmers, which
are mirror image nucleic acid aptamers [3,4]. These Spiegelmers
carry instead of the natural occurring D-ribose, L-ribose, and they
are therefore resistant to natural occurring nucleases. The
resistance of Spiegelmers against nucleases has previously been
reported [3,4,6] and will also be shown in this communication.
Spiegelmers can be generated against a wide range of targets,
since their development makes use of the methods of molecular
evolution [6–10]. So far it has been possible to obtain Spiegelmers
binding small molecules, such as D-adenosine [3] and L-arginine
[4], or pharmaceutically relevant targets including vasopressin,
gonadotropin releasing hormone, ghrelin, substance P, calcitonin
gene-related peptide, pain-related neuropeptide nociceptin and
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relevant proteins, and Staphylococcus enterotoxin [7]. On the basis
of our current knowledge it can be assumed that Spiegelmers can
be developed for the same number of targets, as D-nucleic acid
aptamers [3,4–14]. The pharmacological properties of Spiegel-
mers are very favorable. No negative immunogenic response or
toxicity has been detected so far [7]. Also, up to now, no adverse
side effects have been reported for Spiegelmers, even when applied
in relatively high doses [12,13]. Spiegelmers have found a number
of interesting applications in biotechnology, and recently have
even been entered into their first and second clinical testing phases
as potential pharmaceutical drugs [7,8,14].
In this communication we describe for the first time mirror
image catalytic nucleic acids, i.e., L-RNA hammerhead ribozymes
and L-DNAzymes, constructed on the basis of the known D-RNA
hammerhead ribozyme and D-DNAzyme [15–24] structures.
Because of their mirror image nature to the natural hammerhead
ribozyme and DNAzyme, we named this class of nucleic acid
enzymes Spiegelzymes (Spiegel stands in German for mirror). In
this study we will show that left handed L-RNA ribozymes and L-
DNAzymes are able to induce sequence specific and efficient
hydrolysis of their homochiral RNA targets under in vitro and
in vivo conditions. Thus, the Spiegelzymes fulfill a very essential
and basic prerequisite as potential functional antidotes for
Spiegelmers.
Materials and Methods
RNA and DNA Synthesis
All RNA and DNA oligonucleotides were chemically synthe-
sized by ChemGenes (USA) or by IBA (Germany). The D-RNA1
substrate of 13 nucleotide length had the following sequence: 59-
A1CAGUCGGUCGCC13-39. For the L-RNA1 substrate the same
nucleotide sequence was used, except that the D-nucleotides were
replaced by the corresponding L-nucleotides. Both target forms of
RNA1 were labeled with fluorescein at their 59 ends.
The D-RNA hammerhead ribozyme used for the D-RNA1
target had the following sequence 59-G1GCGACCCUGAU-
GAGGCCGAAAGGCCGAAACUGU34-39, while the L-RNA
hammerhead ribozyme (Spiegelzyme) designed for the L-RNA1
target had the same sequence with the exception that L-
nucleotides, instead of the D-nucleotides, were used in the
sequence of the Spiegelzyme.
The 14 nt sequences of the D-RNA2 and L-RNA2 targets were
the 59-C1UUCAAGUCCGCCA14-39. The difference between
both targets was in that the D-RNA2 consisted of D-nucleotides
and the L-RNA2 target of L-nucleotides. The L-RNA2 target
actually corresponds with its sequence to a fragment of the green
fluorescent protein (GFP) mRNA (positions 252 through 265).
Both target forms of the RNA2 were labeled with fluorescein at
their 59 ends. The hammerhead ribozyme and hammerhead
Spiegelzyme (34 nt) specific for RNA2 had the following sequence:
59-U1GGCGCUGAUGAGGCCGAAAGGCCGAAA-
CUUGA33-39. The difference being that the hammerhead
Spiegelzyme consisted of the L-form of the nucleotides.
The two different DNA1 substrates used were the 59 fluorescein
labeled D- and L- forms with the sequence 59-
A1CAGTCGGTCGCC13-39. Thus, the sequences corresponded
in principle to the target RNA1 sequence.
The chemically synthesized D-DNAzyme and L-DNAzyme
were 27 nucleotides in length with the following sequence 59-
G1GCGGAGGCTAGCTACAACGATTGAAG27-39 in the D-
and L-form respectively.
Target D-RNA1 Hydrolysis with D-Hammerhead
Ribozyme and Target L-RNA1 Hydrolysis with L-
Hammerhead Ribozyme (Spiegelzyme)
The D-RNA1 target was hydrolyzed with the D-hammerhead
ribozyme under the following conditions: 0.2 mM 59 fluorescein
labeled D-RNA was incubated in 10 ml 50 mM Tris-HCl buffer,
pH 7.5, at 37uC in the presence of 1–10 mM MgCl2, at an
ribozyme concentration of 2 mM, and for 2 h unless otherwise
indicated in the legends of the figures. Prior to the reaction the
target D-RNA1 and D-hammerhead ribozymes were denatured
for 2 min at 73uC and cooled to the reaction temperature of 25uC
at 1uC per min in a heating block.
The hydrolysis of the L-RNA1 target with the L-hammerhead
ribozyme was carried out under identical conditions as described
for the D-RNA1 hydrolysis by the D-hammerhead ribozyme.
Target D-RNA2 Hydrolysis with D-DNAzyme and Target L-
RNA2 Hydrolysis with L-DNAzyme (Spiegelzyme)
The activity of D-DNAzyme was analyzed in cleavage reactions,
in which 0.2 mM of 59 fluorescein labeled D-RNA2 was incubated
in 10 ml of a reaction mixture containing 50 mM Tris-HCl buffer,
pH 7.5, 10 mM MgCl2 at 37
o C for 3 h in the presence of 0.02–
10 mM of D-DNAzyme. The enzyme: substrate ratio was 10:1.
Prior to the reaction, the substrate D-RNA2 and D-DNAzyme
were denatured for 2 min at 73oC and cooled to the temperature
of 25oC (1uC/min) in a heating block.
The hydrolysis of the L-RNA target with the L-DNAzyme was
carried out as described for the D-RNA2 target hydrolysis by the
D-DNAzyme, except that the chemically synthesized target and
DNAzyme consisted of L-nucleotides.
Stability Studies of L- and D-Hammerhead Ribozymes
and L- and D-DNAzymes in Different Human Sera
Three different sera preparations where used: two sera were
purchased from Sigma in 1996 and 2009 and one serum was
derived from whole blood of a healthy blood donor, who signed
the ‘‘Agreement for blood donation (Einwilligung zur Blutspende)’’
incl. a detailed questionnaire which German Red Cross Blood
Donor Service East uses for interviewing each blood donor before
blood collection.
Blood was collected without anticoagulant and clotting was
allowed over night at room temperature. The serum tested was
prepared from whole blood of a healthy blood donor who donated
blood at German Red Cross Blood Donor Service East (DRK-
Blutspendedienst Ost gemeinnu¨tzige GmbH). Serum was pre-
pared by centrifugation for 30 min at 3000 rpm in a Heraeus
Megafuge 3 or at 4uC and stored in aliquots at 225uC. Serum was
tested negative for HIV and hepatitis B and C by routine
serological tests.
Stability Studies of L-RNA2 with T1, V1, S1, and T2
Nucleases
The stability of 0.2 mM 59 labeled fluorescein labeled L-RNA1
substrate was studied with T1, V1, S1, and T2 nucleases. The L-
RNA 14-mer was incubated in a 10 ml reaction volume with the
ribonucleases: 10 U T1 ribonuclease (Ambion) was incubated with
the L-RNA1 substrate in a buffer containing 20 mM sodium
citrate (pH 5.0), 7 M urea and 1 mM EDTA, at 55uC for 20
minutes. RNase V1 (Ambion) digestion was carried out by using
10 U of the ribonuclease for 30 min at 25uC in a buffer containing
50 mM Tris-HCl pH 7.2, 100 mM NaCl and 10 mM MgCl2.
The RNase S1 (Promega) digestion was performed by incubating
5 U of the enzyme for 45 min at 37uC in a reaction buffer
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consisting of 50 mM sodium acetate (pH 4.5), 28 mM NaCl and
4.5 mM ZnSO4. The RNase T2 (Promega) digestion was
performed by incubating 2 U enzyme with the L-RNA2 sequence
for 15 min at 37uC. The reaction buffer consisted of 50 mM
sodium acetate pH 4.5, 28 mM NaCl and 4.5 mM ZnSO4.
Figure 1. L-RNA1 Hydrolysis with an L-Hammerhead Ribozyme. (A) Scheme for the potential inactivation of Spiegelmers (L-RNAs) by
Spiegelzymes (L-hammerhead ribozyme). (B) The L-RNA1 and the L-hammerhead ribozyme are presented as the nucleotide sequence specific
homochiral complex. The cleavage site (GUC) in the target L-RNA1 is indicated by an arrow. (C) Analysis of Spiegelmer hydrolysis at 0.1, 0.5, 0.7 and
1 mM MgCl2. Control reactions were carried out with target L-RNA1 alone in buffer and 1 mM MgCl2 (lane C) or with target L-RNA1 and L-
hammerhead ribozyme in buffer without Mg2+ (lane C’). (D, E) Time dependent cleavage of the L-RNA1 target with the L-hammerhead ribozyme
(Spiegelzyme). The hydrolysis of 0.2 mM target fluorescein labeled L-RNA1, with 2 mM or 0.02 mM Spiegelzyme for single (D) and multiple (E) turnover
reactions. The reactions were carried out in 50 mM Tris-HCl, pH 7.5, buffer containing 1 mM MgCl2 at 37uC in total volume of 200 ml. Lanes 1–8 show
the hydrolysis product (6 nt long) after 0, 2, 32, 128 and 256 min, and 24, 48 and 72 h, respectively. (F) A plot of single (squares, solid line) and
multiple (open circles, broken line) turnover reactions. (G) Hydrolysis of the L-RNA1 target with the hammerhead Spiegelzyme in human serum
(Sigma 2009) at different Spiegelzyme to substrate ratios (10:1, 1:1, 1:10). The reactions were carried out at 37uC for 2 h. All reaction products were
separated by 20% polyacrylamide gel electrophoresis (PAGE) with 7 M urea (other details see Materials and Methods) and evaluated by fluorescence
measurement with Fuju Film FLA 5100 phosphoimager (F).
doi:10.1371/journal.pone.0054741.g001
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The RNA sequence ladders were obtained by alkaline
hydrolysis. The incubation was at 95uC for 2 min in 10 ml of
the reaction mixture containing 50 mM NaOH, 1 mM EDTA
and 4 mg of crude tRNA (Serva) and 4 mg of 59- fluorescein labeled
L-RNA2.
Gel Electrophoresis of Enzymatic Reaction Mixtures
Unless otherwise stated the reaction products were separated by
20% polyacrylamide gels containing 7 M urea in 0.09 M Tris-
borate buffer, pH 8.3, and analyzed by a Fuji Film FLA 5100
phosphoimager by using the manufacturer’s software. The
polyacrylamide gels were run at room temperature for four to
six hours using bromophenyl blue as a marker.
Results and Discussion
There were several reasons, which prompted us to try to
develop the Spiegelzymes described in this study. After we had
originally developed the mirror image aptamers called Spiegelmers
[3,4], it was of interest to see, if we could also develop mirror
image nucleic acid enzymes (Spiegelzymes), cleaving sequence
specifically other mirror image nucleic acid targets. On the other
hand, we had also previously observed by x-ray analysis of crystals
grown under microgravity conditions that the D- and L-forms of
RNA molecules differ, not only in their chirality, but that there
were also some differences in which divalent cations and water
molecules could interact with the mirror image molecule at certain
positions [25,26]. This observation could also be very interesting,
when the biological activities of the D-form ribozymes were
compared with the Spiegelzymes. In addition, employing Raman
spectroscopy analysis on the enantiomeric molecules, we could
find out that the natural occurring D-RNA molecules exhibit a
preferential stabilization over the L-RNA forms [27]. Thus, it
would also be of interest to see if these structural differences could
also be correlated to functional differences. Finally, we were also
motivated to perform these experiments in order to find out, if we
could develop mirror image nucleic acid enzymes, which would
hydrolyze sequence specifically L-nucleic acid sequences. If this
were the case, it would then indicate to us that the construction of
highly specific antidotes towards L-nucleic acids, like Spiegelmers,
would be worth to pursue [7,8,14].
Concept to Study L-Hammerhead Ribozyme Activities
The concept of this approach is shown in Figure 1A and the
sequences involved have been demonstrated is shown in Figure 1B.
In this cleavage reaction a hammerhead ribozyme was constructed
in its mirror image form, so that we had an L-RNA hammerhead,
which we also call a hammerhead Spiegelzyme, cleaving an L-
RNA target (L-RNA1). Thus, we engineered a 34 nucleotide long
L-RNA hammerhead ribozyme (Spiegelzyme) for the specific
cleavage of a 13 nucleotide long substrate L-RNA1, containing an
…NGUCQN… sequence at the hydrolysis site (Fig. 1A, B). In vitro
analysis demonstrated that the L-ribozyme can efficiently hydro-
lyze the fluorescein labeled substrate at the predicted site,
producing a 6 nucleotide long fluorescently labeled product
(Fig. 1C).
Studying the Mg++ dependence of the Spiegelzyme reaction, we
observed that at 0, 0.1, 0.5, 0.7 and 1 mM MgCl2, 0, 14, 60, 65
and 75% of the target L-RNA1 was hydrolyzed (Fig. 1C). Higher
magnesium concentrations of 5 and 10 mM (data not shown) did
not improve the yield of the reaction shown in Fig. 1C for 1 mM
MgCl2 at 37uC and 2 h reaction time.
To investigate the kinetic properties of the L-hammerhead
ribozyme in more details, we analyzed the substrate hydrolysis at
single (Fig. 1D, F) and multiple (Fig. 1E, F) turnover conditions, by
using a 10-fold excess of L-ribozyme to L-substrate and L-
substrate to L-ribozyme, respectively. A similar experiment was
was performed with the D-hammerhead and D-RNA1 target (data
not shown). As can be seen in the Fig. 1G the hydrolysis observed
for the L-RNA1 target gave yields of 90 and 20% under these
conditions.
The calculated Kobs for the L-hammerhead ribozyme were
0.014 and 0.024 min21 at single and multiple turnover conditions.
Similar experiments performed with a D-hammerhead ribozyme
and a D-RNA target yielded Kobs of 0.015 and 0.011 min
21 at
single and multiple turnover conditions (data not shown). Thus, we
conclude that both enzymatic reactions exhibit very similar kinetic
properties.
The Spiegelzyme also exhibited very promising catalytic
properties under in vitro conditions with human sera, i.e., in an
commercially purchased human serum (Sigma 2009), and it
showed at L-hammerhead to L-RNA1 ratios of 10:1, 1:1 and 1:10
very effective hydrolysis levels of 94, 77 and 18%, respectively
(Fig. 1G). These results indicate that ionic and buffer conditions
are sufficient for the Spiegelzyme to cleave the target L-RNA1
sequence specifically in human serum. Thus, the results suggest
that the L-hammerhead ribozyme catalyzed cleavage of the L-
RNA1 target could most likely also takes place in living cells.
Can L-Hammerhead Ribozymes Cleave L-DNA Targets?
In another series of experiments we wanted to determine
whether the L-hammerhead ribozyme used in this study would be
able to hydrolyze an L-DNA1 substrate, and if a D-hammerhead
ribozyme would be able to hydrolyze a D-DNA1 substrate. As
expected no activities were observed in MgCl2 range between 1
and 25 mM (Fig. 2). The other experiments indicated in the
Figure 2 with LL and DD represented the homochiral control
experiments in which the L-hammerhead ribozyme hydrolyzed as
expected the target L-RNA1 and the D-hammerhead ribozyme as
also expected the target D-RNA1. Thus, it can be concluded that
an L-hammerhead ribozyme cannot cleave an L-DNA sequence.
Figure 2. Hydrolysis of L-DNA1 by an L-Hammerhead Ribo-
zyme and D-DNA1 by a D-Hammerhead Ribozyme at various
Mg++ Concentrations. Left panel: Target L-DNA1 in buffer without
MgCl2 (C), the same with 25 mM of MgCl2 (C’), Target L-DNA1 with a
hammerhead Spiegelzyme at 1, 5, 10 and 25 mM MgCl2, LL control: L-
RNA1 incubated with L-hammerhead. Right panel: Target D-DNA1 in
buffer without (C’’) and with 25 mM MgCl2 (C’’’). Target D-DNA1 and
hammerhead ribozyme at 1, 5, 10 and 25 mM MgCl2, DD control: D-
RNA1 incubated with D-hammerhead ribozyme. Arrow identifies
hydrolysis site as in Fig. 1B.
doi:10.1371/journal.pone.0054741.g002
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Stability Studies of L-Hammerhead Ribozymes and L-RNA
Oligonucleotides in Human Blood Sera and Specific
Ribonucleases
In order to analyze the stabilities of the L- and D-hammerhead
ribozymes in human serum the experiments shown in Figure 3
were performed. For this experiment two sera of different sources
were used. One was purchased from Sigma in 2009 and it was,
according to Sigma, similarly prepared as the one used in our
earlier stability studies of Spiegelmers in 1996 [3,4], and the
second serum was a donated serum from a patient from the
Charite Hospital Berlin (Fig. 3A and B). The experiments showed
that the hammerhead Spiegelzymes are very stable in the two sera
over a time period of 120 and 144 hrs respectively, and that the
stabilities are similar than those observed for the Spiegelmers in
the human serum from Sigma in 1996 [3,4]. The superior
stabilities of the mirror image hammerhead ribozymes becomes
especially apparent from the control experiment, in which the
hammerhead ribozyme (D-RNA) was incubated with the donated
patients serum and which was already totally hydrolyzed at 1 min
on ice (Fig. 3C).
Although we could prove the stability of L-RNAs in human
sera, it was also of interest to know if the L-RNAs are also resistant
to isolated specific nucleases like T1, V1, S1, and T2. The results
shown in Figure 4 clearly demonstrate that the target L-RNA1 is
not hydrolyzed by any one of these ribonucleases. Thus, also with
this experiment it is documented that the mirror image RNAs are
of superior stability against all different types of nucleases. This
finding would be one of the essential prerequisite if one would
want to employ L-hammerhead ribozymes in cell culture, or
animals or humans.
The hydrolytic activity of the Spiegelzyme was analyzed in the
cells, transfected first with L-RNA substrate and the following day
with the Spiegelzyme. A dose-dependent, 10–40% decrease of L-
RNA isolated from the cells treated with the Spiegelzyme after 24
hours of incubation was observed (Fig. 5).
The above results show for the first time that mirror image
catalytic nucleic acids (Spiegelzymes) can be constructed on the
basis of a hammerhead ribozyme and that these Spiegelzymes are
able to efficiently hydrolyze target L-RNA molecules and that this
hydrolysis can also take place in human sera. Fulfilling these
important prerequisites, it can be foreseen that Spiegelzymes may
qualify for in vivo applications, as for example, as a Spiegelmer
antidote [28,29]. The development of such highly specific
antidotes would be very desirable, especially, if one considers the
fact that Spiegelmers, because of their stability, will have long
pharmacological effects and that this would also be true for
unforeseen side reactions. So far complementary oligonucleotides
have been developed to neutralize unwanted side effects for
aptamers by binding to them [29–31]. With the Spiegelzyme
antidote potentials reported in this study, perfect antidotes would
be at hand to neutralize the Spiegelmers, not only by comple-
mentary oligonucleotide binding, but also by sequence specific
hydrolysis and thus by enzymatic inactivation.
Construction of L-DNAzymes and their Biological
Activities
Next we were interested to analyze the cleavage properties of
another type of nucleic acid ribozyme, i.e. the DNAzyme, which is
a catalytically active single-stranded DNA. DNAzymes recognize
and hydrolyze RNA targets containing a …NGQUN… sequence,
in which N stands for anyone of the common four bases [32].
Advantages of the DNAzymes over hammerhead ribozymes are its
easy chemical synthesis, broad target recognition properties, and a
high catalytic turnover. Numerous application of these catalytic
molecules have been tested, in particular as anticancer therapeu-
tics [22,33].
In the study reported here we designed an L-DNAzyme 10/23
based on L-deoxyribose and we checked its cleavage properties
with an L-RNA2 target (Fig. 6A). The L-RNA2 target used
corresponds in its sequence to positions 252 through 263 of the
green fluorescent protein (GFP) mRNA. The results shown in
Figure 6B and C demonstrate that the L-DNAzyme recognizes
and hydrolyzes the L-RNA2 target and, as expected, that the
normal D-form of the DNAzyme also hydrolyses the D-RNA2
target very efficiently.
Enzymatic Activities of L-Hammerhead Ribozymes and L-
DNAzymes at Different Ribozyme to Target Ratios
In the next series of experiments we compared the hydrolytic
efficiencies of the D-DNAzyme with the D-RNA2 target (Fig. 7A)
and the L-DNAzyme and the L-RNA2 target (Fig. 7B) at different
ribozyme to substrate rations. As can be seen in Figure 6 the
chosen ratios of enzyme to target ranged from 0,1: 1, 1:1, 5:1, 10:1
to 50:1. Under the reaction conditions of 10 mM MgCl2 and 3 hrs
reaction time, a nearly 100% hydrolysis efficiency was reached for
both D- and L-homochiral cases at an enzyme to substrate ration
of 10:1 (Fig. 7C), indicating for both ribozyme cases similar
reaction efficiencies.
Biological Stabilities of L-DNAzymes and D-DNAzymes in
Different Human Sera
Of interest to us was also the question, if the L-DNAzyme would
show similar stability characteristics in different human sera, as the
L-hammerhead ribozyme. As expected the results summarized in
Fig. 8 demonstrate that the mirror image L-DNAzyme is very
stable in the three human sera tested, showing no degradation over
a time period of 72 h (Fig. 8A). Somewhat surprising is the
Figure 3. Hammerhead Spiegelzyme (34-mer) Stability in Human Blood Sera. (A) Incubation at 37uC for 0.25–120 h (6 days) in a human
blood serum purchased from Sigma [4]. (B) Incubation at 37uC for 0.25–144 h in serum derived from a whole blood of a healthy blood donor. Blood
was collected without anticoagulant and clotting was allowed over night at room temperature. Serum was prepared by centrifugation for 30 min at
3000 rpm in a Heraeus Megafuge 3 or at 4uC und stored in aliquots at 225uC. Serum was tested negative for HIV and hepatitis B and C by routine
serological tests. (C) Control-Hammerhead ribozyme (same sequence as the Spiegelzyme) was incubated in serum (as in A) at 37uC for 0.25–120 min.
All diagrams show fractions of the intact L-RNA, or D-RNA at a given time point. C-control sample was incubated on ice over time period given.
doi:10.1371/journal.pone.0054741.g003
Figure 4. Hydrolysis Experiments of L-RNA2 with T1, V1, S1,
and T2 Ribonucleases. Incubation conditions as described under
Materials and Methods. L: alkaline L-RNA2 ladder. The nucleotide
sequence of L-RNA2 is indicated. All nucleases were active against D-
RNA (data not shown).
doi:10.1371/journal.pone.0054741.g004
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observation that the D-DNAzyme showed, even after 4 h
incubations, in the three different sera a significant resistant
toward enzymatic degradation (Fig. 8B). This is in contrast to the
D-hammerhead ribozyme, which showed total hydrolysis even
when incubated at 0uC for 0 minutes (see Fig. 3C). These results
most likely reflect to a certain degree the fact that RNA is in
general much less stable than DNA in cellular fluids.
Figure 5. Hammerhead Spiegelzyme Activities in COS-7 cells. (A) Cells were transfected with 59-fluorescein labeled L-RNA-1 substrates. Prior
to the application of the HH Spiegelzyme, the cells were washed to remove the untransfected substrate from the medium. Then the cells were
transfected with 300, 500, 1000 and 3000 nM of the Spiegelzyme. The control transfection was done only with the substrate. To check for the ability
of the Spiegelzyme to cross the membrane, the cells were transfected with the fluorescein labeled Spiegelzyme (bottom row, right panel). The
microscopic images were taken prior to RNA isolation after washing with PBS buffer. (B) The percentage of uncleaved substrate in the L-RNA-1
isolated from cells transfected with the Spiegelzyme. After incubation for 24 hours, L-RNA was isolated from harvested cells using TRIZOL (Ambion)
according to the manufacturer’s protocol. L-RNA-1 was separated by 20% PAGE with 8 M urea and the amount of substrate was determined by the
fluorescence intensity using Fuji Film FLA 5100 phosphoimager.
doi:10.1371/journal.pone.0054741.g005
Specific Hydrolysis of L-RNA with Spiegelzymes
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Three Dimensional Model Building of L-Hammerhead
Ribozyme and L-DNAzyme Interactions with an L-RNA
Target
The data presented so far in this manuscript demonstrate for the
first time, the construction of two mirror image enzymes, called
Spiegelzymes, namely the L-hammerhead ribozyme and L-
DNAzyme, which can sequence specifically recognize and
hydrolyze homochiral target RNA molecules at low magnesium
concentrations in vitro. These data show also that mirror image
nucleic acids enzymes like L-RNA hammerheads and L-DNA
DNAzymes are equally active as their corresponding enantiomers
in homochiral reactions. Since some slight structural differences
have been reported earlier from us on the basis of x-ray analysis of
RNA crystals from D- and L-RNA molecules, and since these
differences did also involved divalent cation and water interactions
[26,27], it becomes very intriguing to determine the mechanisms
of catalysis of the mirror image enzymes studied in these
experiments. Thus, we have initiated crystallization experiments
involving the L-hammerhead ribozyme and L-DNAzyme com-
plexes with their non-cleavable homochiral targets in order to
determine their atomic structures. With these structures indica-
tions for the mechanisms of these reactions may be obtained and
compared with those for the D-hammerhead ribozyme as
proposed by Scott [20,34].
Nevertheless, since the atomic structures of our L-enzymes with
their L-substrates are currently not known, it may be of interest to
try to get an insight of the mechanism of action of theses
Spiegelzymes by model building. The first attempt in this direction
is shown in Fig. 9.
Figure 9A shows a stereo view of a wire-ribbon model of our L-
RNA hammerhead ribozyme (shown in blue) in complex with the
L-RNA2 target (shown in red). This preliminary model has been
created by using the 2.2 A˚ structure (PDB-ID: 2GOZ) of the full-
length catalytically active hammerhead ribozyme published [34].
This model has been created by first making a simple copy of the
(D-form) highly conserved catalytic centre, which is incapable of
forming canonical Watson–Crick base-pairs. Due to the pure copy
of this catalytic centre all relevant nucleotides (G36 as well as A21
in the structure 2GOZ) lie close enough together, to ensure the
described enzymatic hydrolysis at the cleavage-site nucleotide
(OMC6 in structure 2GOZ and C9 in our model; shown in green
in the Fig. 9A) of the substrate. After that, we built up the atomic
models of three (D-RNA) double helices (H1 to H3) in a standard
A-form by using the secondary structure shown in Fig. 1, but using
the D-RNA2 instead of the D-RNA1 shown in that figure. In the
case of double helix H3, the shape of the hairpin loop has been
created automatically by the hairpin loop folding algorithm of our
ERNA-3D Molecular Modeling Software (PENTAFOLIUM
SOFT). Subsequently, we superimposed these three double helices
over the three double helices (STEM-I to STEM-III) of the
hammerhead ribozyme structure by fitting the bodies of the three
helices as best as possible onto the given STEM helices. Due to the
different nucleotide sequences between the hammerhead ribozyme
(structure 2GOZ) and our proposed model, the hammerhead
ribozyme so far has been used only as submittal shape for the
spatial path of the nucleotide sequences. The double helices have
been superimposed in such a way, that the docking points (the P-
respectively the O39-atoms) at the ends of each helix, which have
to be close enough to both single strands of the catalytic centre,
have been used as the starting points of the helices. In this way, we
were able to connect the different helices with both single strands
of the catalytic centre, without the need to change the spatial
shape of the conserved parts of the hammerhead ribozyme
structure. At last, the L-form of the molecule has simply been
Figure 6. D- or L-RNA2 Hydrolysis by D- or L-DNAzyme. The
general secondary structural model for the D- or L-DNAzyme 10/23 (A),
in complex with a D- or L-RNA2 substrate (B). Hydrolysis of D-RNA2 with
D-DNAzyme at 10 mMMgCl2. Lanes 1: D-RNA2 incubation in water, lane
2: D-RNA2 incubation in 50 mM Tris-HCl pH 7.5 buffer, lane 3: D-RNA2
incubation in the buffer containing in addition 10 mM MgCl2; lane 4: D-
RNA2 hydrolysis with D-DNAzyme in buffer in the absence of MgCl2;
lane 5: D-RNA2 hydrolysis with D-DNAzyme in buffer in the presence of
10 mM MgCl2 (C). L-RNA2 hydrolysis with L-DNAzyme at 10 mM MgCl2,
analyzed with 20% PAGE with 7 M urea. Lanes 1: L-RNA2 incubation in
water, lane 2: L-RNA2 incubation in 50 mM Tris-HCl pH 7.5 buffer, lane
3: L-RNA2 incubation in buffer containing in addition 10 mM MgCl2,
lane 4: hydrolysis of L-RNA with L-DNAzyme in the absence of MgCl2;
lane 5: hydrolysis of L-RNA substrate with L-DNAzyme in presence of
10 mM MgCl2, All incubations were carried out for 3 hrs and analyzed
with 20% PAGE with 7 M urea. Arrows show the specific cleavage site in
the D- and L- RNA2 targets.
doi:10.1371/journal.pone.0054741.g006
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created by the negating of the z-components of the atomic
coordinates [26], in this way the shown mirror image of the
molecule could be created very easily.
In Figure 9B we are showing our attempt to construct a stereo
view of a wire-ribbon model of an atomic model for the L-
DNAzyme (shown in blue) in complex with same L-RNA2 target
(shown in red) and with the cleavage-site at nucleotide G7 (shown
in green). The preliminary model has been created in the same
way, as described for our proposed model of the hammerhead
ribozyme shown in Fig. 9A, by using the submittal shape of the
RNA hammerhead ribozyme (PDB-ID: 2GOZ). Two hybrid
double helices (DH1 and DH2), each consisting of one RNA and
one DNA strand, have been created as standard B-form DNA
helices by using our ERNA-3D software. Subsequently, these two
Figure 7. Hydrolysis of D- or L-RNA2 at different D- or L- DNAzyme ratios. Panel (A) D-DNAzyme hydrolysis of D-RNA2 at enzyme to
substrate ratios as indicated in the lanes of the figure. Lane C: D-RNA2 incubated only in buffer, lane C’: D-RNA2 incubated in buffer with 10 mM
MgCl2. Panel (B) L-DNAzyme hydrolysis of L-RNA2 at enzyme to substrate ratios as indicated in the lanes of the figure. Lane C: L-RNA2 incubated only
in buffer, lane C’: L-RNA2 incubated in buffer with 10 mM MgCl2. (C) D-DNAzyme hydrolysis of D-RNA2 (black circles) at enzyme to substrate ratios as
indicated in the figure and L-DNAzyme hydrolysis of L-RNA2 (gray squares) at ribozyme to substrate ratios shown in the panel. Incubation periods 3 h
for all other conditions see Materials and Methods.
doi:10.1371/journal.pone.0054741.g007
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helices have been superimposed onto the corresponding stems of
the submittal hammerhead ribozyme structure. The docking
points (P-respectively O39-atoms) at the ends of these double
helices have been positioned close enough to the catalytic centre to
ensure the simple connection to both single strands of the
conserved catalytic centre. In the same way as described in
Figure 9A, we used the spatial shapes of both strands (forming the
catalytic centre of the hammerhead ribozyme) to substitute them
with the corresponding DNA nucleotides of our proposed
DNAzyme model. This nucleotide substitution has very easily
been performed by using the Copy-Structural-Motif function
(substitution of nucleotides with nucleotides with different bases,
but at same positions and with same orientations) of our ERNA-
3D software. The remainder of the DNA enzymatic loop, the
nucleotides T14 to A18 (nucleotide numbering of our proposed
model) have also been substituted with the nucleotides of the RNA
double helix of the submittal hammerhead ribozyme, but due to
the fact, that in this case the DNA loop does not form a real double
helix, both strands have been pulled away a little bit by using the
interactive chain translation method of our ERNA-3D software. In
this way, we obtained a shape for the DNA enzymatic loop, which
is similar to an RNA double helix, but which does not form
canonical Watson–Crick base-pairs. At last, the L-form of this
molecule has simply been created by the negating of the z-
components of its atomic coordinates [26].
From our three-dimensional modeling experiments we can
conclude that the sequence specific cleavages of LRNA2 by the L-
hammerhead ribozyme and L-DNAzyme are feasible at the
cleavage points observed in our experiments.
Concluding Remarks
The results obtained in this study demonstrate for the first time
that L-hammerhead ribozymes and L-DNAzymes are capable of
cleaving L-RNA target sequences specifically and very efficiently.
Stability studies performed for the L-hammerhead ribozyme and
L-DNAzyme with three different human sera demonstrated that
these two L-RNA cleaving enzymes are very stable in different sera
even up to the 72 hours tested. This observation is in agreement
with our earlier results obtained with Spiegelmers [3,4]. The
reason for this stability lies in the fact that in nature no nucleic
acids exist in the L-form, just in their D-form. Thus, there have
been no reasons during the evolution to synthesize any enzymes
degrading L-form nucleic acids. The stability of the Spiegelzymes
were further documented by incubation of an L-RNA target with
the commercially obtained ribonucleases T1, V1, S1, and T2.
The fact that the L-hammerhead ribozyme could very efficiently
cleave its L-RNA target, in a human serum, indicates that the
mirror image ribozymes may be suitable for employment in
biological environments.
Considering the efficient activities of the L-hammerhead
ribozyme and L-DNAzyme to hydrolyze sequence specifically L-
RNA sequences, they may be well suited as an antidote against
several Spiegelmers, which are currently in second medical testing
phases by the Noxxon Pharma AG. Not only that, it can also be
envisioned that new kinds of bio chips can be developed on the
Spiegelmer Spiegelzyme basis for diagnostic purposes and the
isolation of specific proteins. Also, the construction of new kind of
nanoparticles should be possible, based upon a combination of
Spiegelmers and Spiegelzymes for the site directed delivery of
drugs.
Intriguing will also be to determine the mechanism how these
mirror image enzymes are functioning and compare those with the
mechanism determined for the natural hammerhead ribozymes.
Here it will be especially interesting, if one could compare the L-
hammerhead ribozyme mechanism with that determined by Scott
and collaborators [21,34] for the natural D-form hammerhead
Figure 8. L-DNAzyme (27-mer) Stability in Different Human Sera. Panel A: L-DNAzyme (Spiegelzyme), Panel B. D-DNAzyme and Panel C: The
% fraction of D-DNAzyme degraded at given times. Sera used in these experiments Sigma 2009 (I), Sigma 1996 (II) and serum isolated from a patient
(III). The DNAzymes were incubated with the sera at 376C for the times indicated in hrs in the panels. Other details see Materials and Methods.
doi:10.1371/journal.pone.0054741.g008
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ribozyme. Since the determination of the three-dimensional
structure at high resolution requires suitable crystals, we are
currently working on the crystallization of the L-hammerhead
ribozyme and the L-DNAzyme. In the meantime we have turned
to three-dimensional model building of the two Spiegelzymes used
in this study. Indeed, we are able to present with this study for the
first time structural models, not only of L-nucleic acids, but for
both Spiegelzymes as they are binding and hydrolyzing their L-
RNA targets.
In summary, with the first description of functionally active L-
hammerhead ribozymes and L-DNAzymes, which were shown to
specifically hydrolyze L-RNA targets the principles are laid down
that these molecules may become important tools for future
applications in biotechnology and molecular medicine. These
theoretical potentials are further supported by the very high
stabilities of these enzymes in human sera, and the recent evidence
that mirror image nucleic acids are not toxic and not immuno-
genic.
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